Task Order 3:Interventional Agent Development Services Program

任务顺序 3：介入药物开发服务计划

• 批准号: 9452777
• 负责人: Jon Carl Mirsalis
• 金额: $ 47.24万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-04-17 至 2018-04-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9452777
• 关键词: Chemistry; Contracts; Development; Intervention; National Institute of Allergy and Infectious Disease; Services; Taenia solium; pre-clinical; programs; therapeutic development; therapy development

This contract provides for chemistry and manufacturing services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

该合同提供了NIAID介入药物开发计划临床前服务下的化学和制造服务。